← All case studies ◆ Public health · Health data analytics

Regional chronic kidney disease prevalence analysis

A healthcare provider needed accurate chronic kidney disease prevalence data for the UAE to guide public health strategy and resource allocation. Umbizo analysed patient data to assess prevalence, identify high-risk groups, and monitor severity.

Medical illustration of the kidneys within the human body

The challenge

A healthcare provider needed accurate prevalence data for chronic kidney disease (CKD) to inform public health strategies and resource allocation in the UAE. Reliable regional figures were required to direct a targeted public health campaign.

What we set out to do

  • Assess CKD prevalence among the patient population
  • Identify high-risk groups
  • Monitor disease severity
  • Generate actionable insights to direct a public health campaign

Our approach

Data collection

Integrated partner institution data and carried out data profiling with clinical leads, applied quality assurance protocols, and performed regional data harmonisation.

Statistical analysis

Built prevalence calculation models, performed risk factor identification and severity stratification, ran time trend analysis, and compared algorithms to assess their suitability.

Reporting implementation

Produced summary statistics, risk group profiling and regional comparisons, and conducted a review of relevant literature to support the findings.

Results and impact

The analysis delivered comprehensive prevalence data, risk factor correlations, severity distributions, and resource utilisation patterns. These informed resource allocation, targeted public health campaign strategies, enhanced risk management, and improved care planning. No specific numeric figures are reported on the page.

“Their health data analytics and genetics expertise have been invaluable to our research initiatives, including contributions to research publications. We look forward to further collaboration.”

Dr P V Shihad, Digital Lead, Aster DM Healthcare

Timeline

  • Initial analysis: 6 weeks
  • Ongoing monitoring cycles

Looking forward

Potential analysis of additional regions with provider coverage, and developing predictive models for disease progression.